Medical Treatment and Prognosis

Abstract

Idiopathic granulomatous mastitis is a benign disease with chronic granulomatous inflammation. Since it was first described, an ideal treatment approach has not yet been established. One of the most important reasons for this is that the etiopathogenesis is not yet clearly understood as well as the heterogeneous clinical appearance within the patient population. It has a very heterogeneous clinical spectrum, and therefore, it may not be correct to apply the same treatment approach to every patient. Today, it is possible to examine the treatment approaches used in IGM under three main headings. These are conservative treatment approaches, surgical interventions, and combined treatment approaches. It will be much more appropriate to choose the treatment option according to the patient. Therefore, a classification for IGM is needed to determine the optimal personalized treatment approach. IGM still remains a mystery, until the etiopathogenesis is fully understood; it seems that the continuation of symptomatic treatment will be the first-line treatment. The only tool we have to guide this mysterious illness is classification schemes. Idiopathic granulomatous mastitis is a benign inflammatory breast disease that is self-limited and can achieve self-remission. Various studies have reported different recurrence rates in IGM patients, depending on the treatment approaches. Studies on factors affecting recurrence in IGM are limited. Idiopathic granulomatous mastitis is also a disease of secondary complications such as infection and delayed wound healing. It is important to maintain long-term follow-up but no measure for prevention has been advised.